Eric’s Bio from Leigh Bureau

Healthcare today is in the midst of a thrilling transformation: the rise of digital medicine. Mobile technology and cheaper gene sequencing are opening the door to a whole new kind of care. Patients, who have tools as good as their doctors, are becoming true partners in caring for themselves. Portable devices are taking care out of hospitals and offices and into everyday life. Real-time tracking is allowing patients to monitor their health at any time — not just at an annual checkup. And the combination of personal trackers and individual gene sequencing will finally replace the outdated model of “population medicine” with true individualized medicine. He is the author on the new book on this subject, The Patient Will See You Now.

This isn’t science fiction. It’s fact — and it’s already happening. His dazzling talks take you on a whirlwind tour of the advances in medical technology happening all around you and show how they will transform your health care and your business. Eric communicates the thrill of working in such exciting, transformational times — and the urgency of not being left behind.

Voted the #1 Most Influential Physician Executive in the United States in a poll conducted by Modern Healthcare, Eric is also one of GQ’s 12 “Rock Stars of Science”. He is the author of the bestselling definitive book on the digital-medical revolution, The Creative Destruction of Medicine.

Eric is also a leading practitioner of digital medicine. He is the director of the flagship NIH-supported Scripps Translational Science Institute and a co-founder of the West Wireless Health Institute. He also serves as Professor of Genomics at The Scripps Research Institute and Chief Academic Officer of Scripps Health. Eric is Editor-in-Chief of a new journal, npj Digital Medicine. Since 2013, he has been Editor-in-Chief at Medscape.

A practicing cardiologist, Eric is widely credited for leading the Cleveland Clinic to become the #1 center for heart care. While there, he also started a new medical school, led many worldwide clinical trials to advance care for patients with heart disease, and spearheaded the discovery of multiple genes that increase susceptibility for heart attacks.

His achievements include the development of many medications that are routinely used in medical practice including t-PA, Plavix, Angiomax, and ReoPro. He was the first physician to raise safety concerns about Vioxx.

In 2011, the University of Michigan initiated the Eric Topol Professor of Cardiovascular Medicine to recognize his contributions. The University of Rochester awarded him the Hutchinson Medal, the University’s highest honor.

One of the top 10 most cited researchers in medicine, Eric has published 1100 peer-reviewed articles and over 30 medical textbooks. His research earned him the title “Doctor of the Decade” from Thomson Reuter’s Institute for Scientific Information.

Credentials

• Director, Scripps Translational Science Institute
• Professor of Genomics, the Scripps Research Institute
• Editor-in-Chief, npj Digital Medicine
• Editor-in-Chief, Medscape
• Chief Academic Officer, Scripps Health
• Elected to Institute of Medicine, National Academy of Sciences in 2004 (newly named National Academy of Medicine in 2015)
• Founder, Cleveland Clinic Lerner College of Medicine